MEA Oncology Information System Market

MEA Oncology Information System Market Size (2022 to 2027)

As per our research report, the size of the Middle East and Africa Oncology Information System has been forecasted at USD 203.45 million in 2022. It is further estimated to be growing at a CAGR of 7.08% and worth USD 286.42 million by 2027.

Cancer is becoming more common in the Middle East and Africa; therefore, the increasing prevalence of cancer is majorly driving the oncology information system market. Also, the growing awareness about the benefits of oncology information systems is boosting the market growth. Furthermore, the ever-increasing population increases the demand for oncology information systems because the senior population is more prone to various chronic diseases. Governments from various countries are working on new legislation to adopt information technology, which is projected to boost the market growth. The growing need to track the many components of oncology therapy and the increasing use of digital tools in healthcare for data storage has propelled the Middle East and Africa oncology information system market.

In addition, the increasing demand for healthcare IT services and the growing usage of blockchain technology in oncology information systems are expected to accelerate the market growth. Furthermore, the integration of oncology information systems to treat rare cancer types and the expanded use of artificial intelligence (AI) in oncology information systems are projected to bring new opportunities to market participants in the near future. Furthermore, the oncology information system market is predicted to expand due to technological improvements and their associated benefits, as well as an increase in cancer occurrence globally. Furthermore, as individuals become more aware of the benefits of ISO, the Latin American oncology system information system market is projected to rise at a quicker rate.

However, high maintenance and service are the primary concerns limiting the market growth. In addition, the difficulties in implementing various networks with health setups and wireless connectivity options further hamper the growth of the oncology information system market in the MEA.

This research report on the Middle East and Africa oncology information system market has been segmented and sub-segmented into the following categories:

By Application: 

• Surgical Oncology
• Medical Oncology
• Radiation Oncology

By Products And Services: 

• Patient Information Systems
• Treatment Planning Systems
• Consulting/Optimization Services
• Implementation Services
• Post-Sale and Maintenance Services

By End Users: 

• Hospitals & Physician’s Offices
• Research Centres
• Government Institutions

By Country: 

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the Middle East Africa is projected to grow at a moderate rate during the forecast period. The market growth is driven by the growing R&D activities, increased cancer cases, and improved healthcare. Furthermore, the government's rising investments in cancer information systems and associated equipment with varying interfaces are expected to boost market growth in emerging countries.

South Africa recorded the largest share of the MEA oncology information systems market, and it is expected to register a significant share during the forecast period. The increasing number of hospitals, availability of advanced treatment facilities for diagnosis, and supportive government policies propel market growth. In addition, the growing number of radiosurgery procedures for fractures, rapid rise in the region's cancer-affected population, and the development of improved radiology information systems and radiation treatment planning systems are all projected to drive the market ahead in the coming years.

On the other hand, emerging countries such as UAE and Saudi Arabia are estimated to witness a considerable share in the market owing to the increasing government institutions and research facilities, growing demand for hospital-based care, and rising healthcare spending.

KEY MARKET PLAYERS:

Companies playing a key role in the MEA oncology information system market profiled in the report are Accuray Incorporated (U.S.), Altos Solutions, Inc. (U.S.), Cerner Corporation (U.S.), Elekta AB (Sweden), Epic Systems Corporation (U.S.), Koninklijke Philips N.V. (The Netherlands), McKesson Corporation (U.S.), and Varian Medical Systems, Inc. (U.S.).